Abdullah Alhadhira, MD, is fellow in disaster medicine and disaster medicine and emergency management at Beth Israel Deaconess Medical Center IDMC and research fellow in disaster medicine at Harvard Medical School. He is a former acting chief and head physician of Saudi ARAMCO Emergency Departments and remote area clinics. Abdullah is secretary-general of Saudi Society of Emergency Medicine (SASEM) and board member of the Saudi Arabia Emergency Medicine National Support Program. He is an emergency medicine board certified graduate of the University of Western Ontario.
Natasha Aljalian, MBE, JD, LLM, is a member of the Boston Children’s Hospital (BCH) Family Advisory Council and will begin serving on the BCH Ethics Advisory Committee in the fall. She received her BA from Hofstra University in psychology, a JD from St. John's University School of Law where she was editor-in-chief of the Law Review, an LLM from Boston University School of Law with a concentration in intellectual property law, and most recently a master of bioethics from Harvard Medical School.
Diana Anderson, MD, MArch, is an evidence-based design researcher at the McGill University Health Centre. She received her bachelor of science in architecture and master of architecture from McGill University, and her MD from the University of Toronto. She completed her internal medicine residency at New York-Presbyterian Hospital, Columbia University Medical Center. She is interested in bioethics related to health care spaces, including the application towards design guidelines.
Irina Anselm, MD, is an attending physician in neurology at Boston Children’s Hospital. She received her MD from St. Petersburg Pediatric Medical University in Russia. As more and more genetic testing options become available, the more ethical dilemmas arise in areas such as the dissemination of test results, health care coverage, and public health care policy; she is interested in these ethical aspects surrounding genetic testing. She received the Making a Change for Mito Award from the MitoAction: Mitochondrial Disease Action Committee.